Health

Psoriasis is known as an autoimmune skin condition that affects millions globally, leading to red, scaly patches on the skin. The chronic nature of this disease manifests not only physically but also impacts psychological well-being. Recent research emerging from France has unveiled a concerning correlation between the activity of psoriasis and the consumption of ultraprocessed

The Centers for Medicare & Medicaid Services (CMS) has recently put forth a proposed rule aimed at increasing transparency and fairness in Medicare Advantage (MA) plans. This initiative, a part of the broader efforts by the Biden administration, seeks to reform prior authorization processes, thereby allowing patients to gain better access to necessary healthcare services.

Meningiomas represent a significant portion of primary brain tumors, known for their diverse behavioral patterns and treatment responses. The burgeoning field of neuro-oncology has consistently sought to refine surgical techniques to improve patient outcomes. One intriguing method that has gained traction is preoperative embolization, a procedure designed to reduce blood flow to the tumor before

The healthcare sector often finds itself in a battleground of regulatory dilemmas, where scientific advancement intersects with the intricate web of policies and societal expectations. At a recent FDA advisory committee meeting, Donald Kohn, MD, highlighted the challenges faced while deliberating the approval status of the bleeding reversal agent andexanet alfa (Andexxa). This situation illustrates

As the political landscape evolves in response to the recent presidential election, the health sector sees significant changes that promise to spark heated debates and provoke a mixture of hope and concern. President-elect Donald Trump has selected Dr. Dave Weldon for the role of Director of the Centers for Disease Control and Prevention (CDC) and

The nomination of Dr. Marty Makary to lead the Food and Drug Administration (FDA) has sparked discussions about the future of public health policy in the United States. As a recognized figure within the medical community and a proponent of unconventional health viewpoints, Makary’s appointment under President-elect Donald Trump poses a significant shift in FDA

Chronic pain has emerged as a significant public health issue in the United States, affecting nearly one in four adults according to recent data from the Centers for Disease Control and Prevention (CDC). A survey conducted in 2023 revealed that 24.3% of adults have experienced chronic pain lasting three months or longer. This dramatic statistic

The FDA’s advisory committee recently reached a pivotal decision, signaling a potential transformation in the management of schizophrenia treatments by voting to eliminate the Risk Evaluation and Mitigation Strategy (REMS) associated with clozapine. Given that clozapine is a critical medication for treatment-resistant schizophrenia, this move has sparked significant discussions within the medical community regarding the

Docosahexaenoic acid (DHA), a key omega-3 fatty acid, has garnered significant attention in the realm of cognitive health, particularly in the context of dementia and memory-related diseases. As research evolves, scientists are continuously evaluating the effectiveness of DHA supplementation on brain function and structural integrity. The latest findings from the PreventE4 trial, presented during the

In recent times, the focus on public health measures has underscored the importance of flu vaccinations, particularly for individuals with heightened health risks, such as those with a history of acute myocardial infarction (MI). A study derived from three comprehensive clinical trials conducted in Denmark shines a light on how electronic nudges have made a